Latest News

22 Attorneys General Unite Against Trump Administration’s NIH Grant Cost Cap: A Threat to University Funding

Frank Dolan February 10, 2025

Emerging Innovations in Acromegaly Treatments: Revolutionizing the Landscape

Arsenal February 7, 2025

Top 14 Biotech Podcasts to Follow in 2025: Your Guide to the Future of Biotechnology

Frank Dolan February 7, 2025

Trade Group of 1,600 Hospitals Opposes Eli Lilly’s 340B Rebate Model: A Call to Action

Frank Dolan February 7, 2025

Circular RNA: The Next Biopharma Revolution Beyond mRNA

Arsenal July 31, 2024

GSK, Flagship Invest $150M in Respiratory and Immunology Programs

Arsenal July 30, 2024

Amylyx Rebounds with GLP-1 Drug Acquisition and Promising Pipeline

Arsenal July 24, 2024

A thought-provoking illustration showing a person cross-legged on the floor, surrounded by medical bills, looking longingly at a distant, glowing silhouette of a therapist through a symbolic barrier made of dollar signs, reflecting the theme of financial barriers to mental health care in the United States.

Does Medical Debt Lead to Postponed Mental Health Care in the USA?

Frank Dolan July 19, 2024

An illustration of a happy person standing on a scale, showing a significant weight loss achievement, with CT-996 molecule structures and icons for obesity and type 2 diabetes floating around them.

CT-996 Shows Notable Weight Reduction in Obese Individuals with Type 2 Diabetes

Frank Dolan July 18, 2024

Biotech Layoffs: Navigating Legal Risks During Restructuring

Arsenal July 17, 2024

Eli Lilly’s Tirzepatide: A Potential Game-Changer in Weight-Loss Drugs

Arsenal July 16, 2024

An illustrated scene showing a team of scientists in a futuristic lab joyously discovering a breakthrough treatment for acute myeloid leukemia, with the FDA Fast Track Designation certificate displayed prominently in the foreground.

FDA Accelerates Review of Sumitomo Pharma’s New Therapy for Patients with Relapse or Treatment-Resistant Acute Myeloid Leukemia

Frank Dolan July 15, 2024

Congress: Renew FDA Pediatric Rare Disease Program

Arsenal July 15, 2024

Reauthorize FDA’s Priority Review Voucher Program for Pediatric Rare Diseases

Arsenal July 15, 2024

FDA Rejects Novo’s Once-Weekly Insulin Icodec: 2024 Decision Tracker

Arsenal July 12, 2024

An illustration of a futuristic digital library with glowing books and holographic data charts, symbolizing registries of real-world evidence (RWE) being used to meet regulatory standards in healthcare.

Achieving Regulatory Standards: Using Registries as a Source of Regulatory-Quality Real-World Evidence

Frank Dolan July 11, 2024

Top 10 Tips to Harness AI’s Power in Biotech Drug Development

Arsenal July 10, 2024

Mesoblast Resubmits BLA to FDA for Ryoncil in Pediatric SR-aGVHD Treatment

Arsenal July 9, 2024

BioCity’s SC0062 Meets Primary Endpoint in Phase 2 IgA Nephropathy Trial

Arsenal July 8, 2024

Doer Biologics Completes Enrollment in DR10624 Obesity and Hypertriglyceridemia Trial

Arsenal July 5, 2024

Stay up to date on the latest news

By pressing the Subscribe button, you confirm that you have read our Privacy Policy.

Eli Lilly Partners with Rznomics: A $1.3 Billion Breakthrough in Gene Therapy for Sensorineural Hearing Loss

Jiangsu Hengrui Targets $1.2 Billion IPO: A Leap Forward for Biotech Innovation

Novo Nordisk and Septerna Join Forces: A Game-Changer in Oral Obesity Drug Development

Email Us

info at arsenal-advisors.com

Headquarters

Cambridge, MA USA